Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the previous revision v3.4.1 was removed. The government-funding lapse notice was also removed.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page now displays a government funding lapse notice and an updated site revision note (v3.4.1), with the previous revision (v3.4.0) removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdditions include a glossary display and new status labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus 'No FEAR Act Data' and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section with Georgia listed as a site. Also removed the HHS Vulnerability Disclosure and Georgia Locations entries, and updated the revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of Revision: v3.2.0. This reflects a site update/versioning detail.SummaryDifference0.1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.